Long-term follow-up of recovered MPN patients with COVID-19

Blood Cancer J. 2021 Jun 16;11(6):115. doi: 10.1038/s41408-021-00509-0.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • COVID-19 / complications*
  • COVID-19 / mortality
  • COVID-19 / therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Leukemia, Myeloid, Acute / complications*
  • Leukemia, Myeloid, Acute / mortality
  • Leukemia, Myeloid, Acute / therapy
  • Lymphoma, Non-Hodgkin / complications*
  • Lymphoma, Non-Hodgkin / mortality
  • Lymphoma, Non-Hodgkin / therapy
  • Male
  • Middle Aged
  • Myeloproliferative Disorders / complications*
  • Myeloproliferative Disorders / mortality
  • Myeloproliferative Disorders / therapy
  • SARS-CoV-2 / isolation & purification
  • Treatment Outcome